• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Oct31
Nanobiotix SA Enters into Royalty Monetization Agreement with Healthcare Royalty
07:01
Oct24
Nanobiotix transfers head and neck cancer trial control to Johnson & Johnson
06:00
Oct4
Nanobiotix SA ADR Reports Significant H1 2025 Revenue Growth, Narrowed Net Loss
03:56
Oct1
Nanobiotix SA released FY2025 Semi-Annual Earnings on September 30 (EST), actual revenue USD 30.01 M (forecast USD 8.154 M), actual EPS USD -0.1278 (forecast USD -0.4448)
03:00
Nanobiotix SA released FY2025 Q2 earnings on September 30 (EST), actual revenue USD 15.59 M, actual EPS USD -0.0664
03:00
Nanobiotix SA released FY2025 Q1 earnings on September 30 (EST), actual revenue USD 14.42 M, actual EPS USD -0.0614
03:00

Schedules & Filings

Schedules
Filings
Sep30
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 15.59 M, Net Income -3.151 M, EPS -0.0664

Apr2
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue -8.57 M, Net Income -24.06 M, EPS -0.5088

Sep18
Earning Release(EST)

FY2024 Q2 Earning Release (USD) Revenue 4.975 M, Net Income -11.72 M, EPS -0.2485

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
CDTX
217.710
+105.41%
+111.720
CYPH
2.750
+56.25%
+0.990
CYCU
6.320
+51.20%
+2.140
WSHP
30.210
+50.90%
+10.190
CMCT
9.250
+36.43%
+2.470
IVVD
2.350
+32.77%
+0.580
TOI
3.970
+28.90%
+0.890
NOMA
7.600
+26.46%
+1.590
CNTB
2.120
+26.19%
+0.440
GTBP
0.9206
+26.14%
+0.191
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy